Results 161 to 170 of about 2,705 (182)

Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi [PDF]

Clinical Infectious Diseases, 2019
BACKGROUND: Typhoid fever is an acute infection characterized by prolonged fever following the ingestion and subsequent invasion of Salmonella enterica serovar Typhi (S. Typhi), a human-restricted pathogen.
James E Meiring, Matthew B Laurens, Pratiksha Patel   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Typhoid Conjugate Vaccine: A Solution to Protect from Typhoid Fever

Journal of Wazir Muhammad Institute of Paramedical Technology, 2021
Typhoid fever results from enteric infections caused by salmonella typhi, which is a gram-negative, rod-shaped flagellated bacteria. Humans are the only host for salmonella typhi thereby causing typhoid fever, which is a progressively rising, life-threatening fever with a cluster of clinical symptoms.
openaire   +1 more source

Efficacy of typhoid conjugate vaccine in Malawian children

Lancet, The
exaly   +3 more sources

A conjugate vaccine against typhoid fever

The Lancet Infectious Diseases, 2014
Se Eun, Park, Florian, Marks
openaire   +2 more sources

Typhoid-vaccine-Vi-conjugate

Reactions Weekly, 2022
openaire   +1 more source

Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial

Lancet, The, 2021
Firdausi Qadri, Xinxue Liu, Katherine Theiss-Nyland   +2 more
exaly  

Towards a marketplace for Vi polysaccharide-conjugate typhoid vaccines

The Lancet Infectious Diseases, 2022
openaire   +2 more sources

Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9–15 months old Nepalese infants

Vaccine, 2022
Ganesh Kumar Rai, Birendra Prasad Gupta, T Anh Wartel   +2 more
exaly  

Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso

International Journal of Infectious Diseases, 2021
Alphonse Ouedraogo, Nouhoun Barry, Mohamadou Siribié   +2 more
exaly  

Assessment of vaccine herd protection in a cluster-randomised trial of Vi conjugate vaccine against typhoid fever: results of further analysis

EClinicalMedicine, 2023
Farhana Khanam, Deok Ryun Kim, Xinxue Liu   +2 more
exaly